BiotechTube
Home/Alteron Therapeutics/Trish Sinnott
TS

Trish Sinnott

Investor Relations

Alteron Therapeutics

Therapeutic Areas

NeurologyRare DiseasesPulmonology

Alteron Therapeutics Pipeline

DrugIndicationPhase
ALTA-808Amyotrophic Lateral Sclerosis (ALS)Preclinical
ALTA Drug SeriesAlzheimer's DiseasePreclinical

Leadership Team at Alteron Therapeutics

CZ
Chengliang Zhang
Chief Executive Officer
CF
Chandler Fang
Co-Founder
BM
Biao Ma
Scientist
View full Alteron Therapeutics profile